CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs Five-Year Clinical Outcomes After Drug-Eluting Stent Implantation Following Rotational Atherectomy for Heavily Calcified Lesions Incidence and Standardized Definitions of Mitral Valve Leaflet Adverse Events After Transcatheter Mitral Valve Repair: the EXPAND Study The Tricuspid Annular Plane Systolic Excursion to Systolic Pulmonary Artery Pressure Index: Association With All-Cause Mortality in Patients With Moderate or Severe Tricuspid Regurgitation Pathophysiology, diagnosis and new therapeutic approaches for ischemic mitral regurgitation Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry 5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Novel Transcatheter Mitral Valve Prosthesis for Patients With Severe Mitral Annular Calcification Risk of Atrial Fibrillation According to Cancer Type: A Nationwide Population-Based Study

Original Research2013 Mar 19;108(5):1071-8.

JOURNAL:Br J Cancer. Article Link

Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs

van Leeuwen RW, Brundel DH, Neef C et al. Keywords: cardio-oncology; drug interaction; prevalence; oral anticancer drug;

FULL TEXT PDF